Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network

Krolewski, 2014, Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria, Diabetes Care, 37, 226, 10.2337/dc13-0985 Molitch, 2010, Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study, Diabetes Care, 33, 1536, 10.2337/dc09-1098 Caramori, 2003, Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions, Diabetes., 52, 1036, 10.2337/diabetes.52.4.1036 Drummond, 2002, International Diabetic Nephropathy Study G. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes, Diabetes, 51, 1580, 10.2337/diabetes.51.5.1580 American, 2019, 11. Microvascular complications and foot care: standards of medical Care in Diabetes-2019, Diabetes Care, 42, S124, 10.2337/dc19-S011 Kdoqi, 2007, KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease, Am J Kidney Dis, 49, S12, 10.1053/j.ajkd.2006.12.005 Diabetes, 2009, Arch Intern Med, 169, 1307, 10.1001/archinternmed.2009.193 Mauer, 2009, Renal and retinal effects of enalapril and losartan in type 1 diabetes, N Engl J Med, 361, 40, 10.1056/NEJMoa0808400 National, 2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1 Diabetes, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Group DER, 2011, de Boer IH, Sun W, et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes, N Engl J Med, 365, 2366, 10.1056/NEJMoa1111732 Group TES, 2003, Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study, JAMA., 290, 2159, 10.1001/jama.290.16.2159 Laffel, 1995, The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria, North American Microalbuminuria Study Group Am J Med, 99, 497 Lewis, 1993, The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group, N Engl J Med, 329, 1456, 10.1056/NEJM199311113292004 Beck, 2012, The T1D exchange clinic registry, J Clin Endocrinol Metab, 97, 4383, 10.1210/jc.2012-1561 Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 Schwartz, 2009, New equations to estimate GFR in children with CKD, J Am Soc Nephrol, 20, 629, 10.1681/ASN.2008030287 Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study. Lancet Diabetes Endocrinol. 2014;2(10): 793–800. Beck, 2017, Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial, JAMA, 317, 371, 10.1001/jama.2016.19975 Tumminia, 2015, Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial, Diabetes Metab Res Rev, 31, 61, 10.1002/dmrr.2557 Foster, 2019, State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018, Diabetes Technol Ther, 21, 66, 10.1089/dia.2018.0384 Ku, 2016, Association between blood pressure and adverse renal events in type 1 diabetes, Diabetes Care, 39, 2218, 10.2337/dc16-0857 Orchard, 2001, Pittsburgh Epidemiology of Diabetes Complications S. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh epidemiology of diabetes complications study, Diabetes Care, 24, 1053, 10.2337/diacare.24.6.1053 Tuttle, 2014, Diabetic kidney disease: a report from an ADA consensus conference, Am J Kidney Dis, 64, 510, 10.1053/j.ajkd.2014.08.001 Benitez-Aguirre, 2017, Early changes of arterial elasticity in type 1 diabetes with microvascular complications - a cross-sectional study from childhood to adulthood, J Diabetes Complicat, 31, 1674, 10.1016/j.jdiacomp.2017.08.007 Gordin, 2011, Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (The FinnDiane Study), Diabetes Care, 34, 886, 10.2337/dc10-2013 Lievre, 2005, Cross-sectional study of care, socio-economic status and complications in young French patients with type 1 diabetes mellitus, Diabetes Metab, 31, 41, 10.1016/S1262-3636(07)70165-9 Secrest, 2011, Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh epidemiology of diabetes complication (EDC) study, Ann Epidemiol, 21, 374, 10.1016/j.annepidem.2011.02.007 Toppe, 2017, Socio-economic factors influencing the development of end-stage renal disease in people with type 1 diabetes - a longitudinal population study, Diabet Med, 34, 676, 10.1111/dme.13289 Karges, 2017, Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes, JAMA., 318, 1358, 10.1001/jama.2017.13994 Rosenlund, 2015, Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study, Diabet Med, 32, 1445, 10.1111/dme.12950 Heinemann, 2015, Diabetes Care, 38, 716, 10.2337/dc15-0817